Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 28 (6) , 533-542
Abstract
No abstract availableKeywords
Funding Information
- Institutional funds of the University of Bologna
This publication has 46 references indexed in Scilit:
- Standardisation of the FAERS database: a systematic approach to manually recoding drug name variantsPharmacoepidemiology and Drug Safety, 2015
- Effect of Competition Bias in Safety Signal GenerationDrug Safety, 2012
- Reporting Patterns Indicative of Adverse Drug InteractionsDrug Safety, 2011
- A potential competition bias in the detection of safety signals from spontaneous reporting databasesPharmacoepidemiology and Drug Safety, 2010
- Quantitative signal detection using spontaneous ADR reportingPharmacoepidemiology and Drug Safety, 2009
- Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous DefinitionsDrug Safety, 2009
- Effect of Date of Drug Marketing on Disproportionality Measures in PharmacovigilanceDrug Safety, 2009
- Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting DatabasesDrug Safety, 2007
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Channeling bias in the interpretation of drug effectsStatistics in Medicine, 1991